Rafaella Wallace
Gerontology · Fort Worth, TXNPI 1821469107
Payments from drug & device makers
Across 76 payments — averaging $32.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$379
- Myriad Genetic Laboratories, Inc.$262
- Seagen Inc.$243
- Janssen Scientific Affairs, LLC$158
- AstraZeneca$157
- GSK$153
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,30293%
- Education$1817%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 10 | $379 |
| Myriad Genetic Laboratories, Inc. | 5 | $262 |
| Seagen Inc. | 6 | $243 |
| Janssen Scientific Affairs, LLC | 4 | $158 |
| AstraZeneca(2 entities) | 5 | $157 |
| GSK | 3 | $153 |
| Blueprint Medicines Corporation | 2 | $148 |
| Johnson & Johnson | 2 | $137 |
| Merck | 6 | $136 |
| Sobi, Inc | 5 | $109 |
| E.r. Squibb & Sons, L.L.C. | 3 | $92 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Gilead | 4 | $63 |
| Bristol Myers Squibb | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Karyopharm Therapeutics Inc. | 1 | $32 |
| Shield Therapeutics Inc | 1 | $31 |
| Pfizer | 2 | $31 |
| Amgen | 1 | $28 |
| Novartis | 1 | $25 |
| Sanofi | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Tempus AI, Inc | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Beigene USA, Inc. | 1 | $16 |
| BD | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,483 in reported general payments places this provider in the 80th percentile of 653 gerontology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImbruvicaIbrutinib | 23 | $359,692 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 36 | $242,519 |
| Anastrozole | 18 | $352 |
| Ondansetron OdtOndansetron | 19 | $319 |
| Olanzapine | 20 | $161 |
| Potassium Chloride | 12 | $145 |
| Gabapentin | 19 | $140 |
| Lorazepam | 13 | $30 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Fort Worth
- Jennifer WestFort Worth$67K
- Patricia MagnessFort Worth$5K
- Kimberly PoseyFort Worth$4K
- Kimberly WelchCoppell$113K
- Tiffany KesslerDallas$84K
- Meagan ChavarriaHouston$40K
- Bailey EstesAbilene$34K
- Scott ZelaHouston$28K
- Marissa Marti-SmithDallas$27K
- Andrew BargerAustin$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.